Trials to test hydroxychloroquine, an inhibitor of autophagy, for pancreatic cancer are in progress. A recent study suggests that, in some circumstances, hydroxychloroquine may hasten the progression to invasive pancreatic ductal adenocarcinoma.
No takes yet. Share an insight, caveat, or question.
Iacobuzio–Donahue et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: